Nonselective ETA/ETB receptor antagonist blocks proliferation of rat vascular smooth muscle cells after balloon angioplasty
- 12 May 1995
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 56 (25) , PL449-PL454
- https://doi.org/10.1016/0024-3205(95)00219-v
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cyclic Hexapeptide Endothelin Receptor Antagonists Highly Potent for Both Receptor Subtypes ETA and ETBBiochemical and Biophysical Research Communications, 1994
- Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells.Endocrinology, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Endothelin-1 and Endothelin Receptor mRNA Expression in Normal and Atherosclerotic Human ArteriesBiochemical and Biophysical Research Communications, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Molecular characterization of endothelin receptorsTrends in Pharmacological Sciences, 1992
- Endothelin is a potent mitogen for rat vascular smooth muscle cellsAtherosclerosis, 1989
- Re-Stenosis after Successful Coronary AngioplastyNew England Journal of Medicine, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens.The Journal of cell biology, 1981